TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives $11.56 Consensus PT from Analysts
Shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSI – Get Free Report) have been given an average rating of “Buy” by the ten research firms that are covering the stock, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average […]
Shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSI – Get Free Report) have been given an average rating of “Buy” by the ten research firms that are covering the stock, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average […]
